Skip to main content
Premium Trial:

Request an Annual Quote

BioSystems International Installs Spotfire s DecisionSite Software

NEW YORK, Dec. 13 (GenomeWeb News) - BioSystems International has purchased Spotfire's flagship DecisionSite software, the company said today. 

 

BSI has deployed DecisionSite to investigate and analyze several classes of biomarkers, including stratification markers that predict the likelihood of a drug response; efficacy biomarkers that predict a clinical outcome; screening markers for the early detection of diseases; and prognostic markers to predict the likely course of the disease, Spotfire said.

 

Financial terms of the deal were not disclosed.